Skip to content
Search

Latest Stories

Lords back amendment to exempt pharmacies from national insurance hike

Members of the House of Lords approved four changes to the National Insurance Contributions (Secondary Class 1 Contributions) Bill at the report stage

National Insurance Bill debated in the the House of Lords

National Insurance Bill debated in the the House of Lords

Pharmacies are expected to be exempted from national insurance contributions following an amendment to the National Insurance Contributions (Secondary Class 1 Contributions) Bill, which was approved by the House of Lords on Tuesday, 25 February 2025.

In the 2024 Autumn Budget, Chancellor Rachel Reeves announced an increase in the employer secondary Class 1 National Insurance contributions rate, rising from 13.8% to 15% starting in April 2025.


Health and care providers, including community pharmacists, have been calling on the government to reconsider their decision and grant them an exemption from the increase.

Malcolm Harrison, chief executive of the Company Chemists’ Association (CCA) welcomed the strong backing for this amendment in the Lords, stating: “It is absolutely right that pharmacies should be exempted from the increase to National Insurance contributions.”

He pointed out that pharmacy businesses earn as much as 90-95% of their income by delivering NHS care and services, but the amount that the government pays for these services has not increased since 2014.

“As increased operating costs cannot be passed on to the NHS or to patients, pharmacy businesses have been forced to simply absorb them.

“We urge Peers to pass this amendment and hope that MPs will also follow suit.”

Nick Kaye, Chair of the National Pharmacy Association (NPA), emphasised that this amendment would help pharmacies manage a looming bill of hundreds of millions of pounds.

"This comes in the context of 40 per cent cuts to pharmacy budgets, forcing record numbers to close,” he said.

Kaye reiterated that if the government fails to provide additional support in the new contract, they would be forced to recommend pharmacies to cut back services, including their opening hours, to protect their businesses.

The NPA estimated that rises in National Insurance and the National Living Wage would collectively cost pharmacies across the UK £310 million.

Baroness Barker, who introduced the amendment, warned that sudden changes to national insurance, along with the increases in the minimum wage, could threaten “the existence of large numbers of providers and have a profound impact on budgets.”

Lords voted to agree four changes to the Bill aimed at maintaining current national insurance contribution rates or granting exemptions from the planned increase. These changes apply to:

  • Health and care providers, including GPs, dentists and pharmacists
  • Charities with annual revenue less than £1 million
  • Transport providers for children with special educational needs and disabilities
  • Low earning or low employee businesses and organisations.

Additionally, members agreed to increase employment allowance in the early years sector to £20,000 and require

However, two proposed amendments—one on new contribution rates for part-time workers and another on maintaining current rates for sectors such as universities, councils, and housing associations—were put to a vote but rejected.

The Third Reading, which ensures the new law is effective, workable and without loopholes, is scheduled for 4 March.

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less